Abstract
To analyze the clinical characteristics of recurrence of vulvar squamous cell cancer and to explore the treatment thereof. The clinical data of 18 patients vulvar squamous cell cancer, confirmed at the age 28-76, who developed recurrence were retrospectively analyzed. The overall recurrence rate was 21.3%. The time range between the primary operation and the discovery of primary recurrence was 2 months - 16 years. Local recurrence occurred in 11 of the 18 patients (61.1%). Recurrence in groin alone occurred in 4 of the 10 patients (22.2%) and recurrence in both the vulva and groin occurred in 3 of the 18 patients (16.7%). Local recurrence occurred more than 1 year after the primary treatment and inguinal recurrence occurred mostly within 1 year after the primary treatment. The survival time of the patients with vulvar recurrence was (63.2 +/- 8.1) months, significantly longer than that of the patients with groin recurrence [(10.7 +/- 1.6) months, P < 0.01]. The clinical characteristics and the prognosis of recurrent vulvar squamous cell cancer depend on the site of recurrence. The best treatment option for recurrence is surgery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
